$3.57 Million is the total value of TYNDALL CAPITAL PARTNERS L P's 3 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MMAC | MMA CAP MGMT LLC | $1,828,000 | -3.7% | 72,552 | 0.0% | 51.26% | +114.0% | |
| ONTX | ONCONOVA THERAPEUTICS INC | $1,722,000 | -71.3% | 816,272 | 0.0% | 48.29% | -36.1% | |
| ONTXW | ONCONOVA THERAPEUTICS INC*w exp 07/11/202 | $16,000 | -59.0% | 390,624 | 0.0% | 0.45% | -8.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Confidential | 19 | Q2 2023 | 0.0% |
| ONCONOVA THERAPEUTICS INC | 14 | Q4 2019 | 21.2% |
| MMA CAP MGMT LLC | 13 | Q4 2019 | 99.4% |
| ONCONOVA THERAPEUTICS INC | 8 | Q2 2018 | 78.8% |
| 0 | 8 | Q2 2015 | 0.0% |
| ONCONOVA THERAPEUTICS INC | 5 | Q3 2019 | 75.6% |
| CYCLERION THERAPEUTICS INC | 4 | Q2 2024 | 100.0% |
| PENDRELL CORP | 2 | Q3 2017 | 54.6% |
View TYNDALL CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclerion Therapeutics, Inc. | February 14, 2024 | 164,429 | 6.7% |
| Onconova Therapeutics, Inc. | February 14, 2020 | 26,042 | 0.1% |
| Ottawa Savings Bancorp, Inc. | February 17, 2015 | 130,237 | 6.1% |
| Eagle Bancorp Montana, Inc. | February 14, 2012 | 119,790 | 3.1% |
| First Financial Northwest, Inc. | February 14, 2012 | 373,168 | 2.0% |
| Myrexis, Inc.Sold out | February 14, 2012 | 0 | 0.0% |
| WAYNE SAVINGS BANCSHARES INC /DE/ | February 14, 2012 | 64,720 | 2.2% |
| Furiex Pharmaceuticals, Inc. | July 29, 2011 | 13,872 | 0.1% |
| Ocean Shore Holding Co. | February 14, 2011 | 324,000 | 4.4% |
| WALTER INVESTMENT MANAGEMENT CORP | February 14, 2011 | 304,700 | 1.2% |
View TYNDALL CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-03 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-05 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View TYNDALL CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.